Martin Brusdeilins
Martin Brusdeilins
In the course of a 30-year career, Brusdeilins held several executive management board positions covering R&D, Portfolio Management, Operations and worldwide Marketing at Tecan (Switzerland), Ortho-Clinical Diagnostics (Rochester, NY) and Roche Diagnostics (Indianapolis, IN, and Graz, Austria, as well as Mannheim, Germany). His work encompasses the fields of clinical diagnostics, immunodiagnostics, immunohematology, immunohistochemistry, molecular diagnostics, blood screening systems and point of care. Brusdeilins is a Member Industry Council to the School of Applied Chemistry at Reutlingen University, Germany, a Member of the Board of Directors of Toolpoint, Switzerland, a member of the Presidents Roundtable to the president of Rochester Institute of Technology, Rochester, NY, USA and has served as Vice Chair of the Board of Directors of MedTech in Upstate New York and as member of the Industrial Advisory Board to the University at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) at the New York State Center of Excellence in Bioinformatics and Life Sciences.